US Bancorp’s Agilon Health AGL Stock Holding History

US Bancorp’s Portfolio AGL Stock Details AGL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.86K	Buy	+36	New	+$2.36K	﹤0.01%	3725
2025 Q3	–	Sell	-1,537	Closed	-$88.4K	–	4003
2025 Q2	$88.4K	Buy	1,537 +1,430	+1,336%	+$115K	﹤0.01%	2485
2025 Q1	$11.5K	Buy	107 +13	+14%	+$1.13K	﹤0.01%	3385
2024 Q4	$4.47K	Sell	94 -33	-26%	-$2K	﹤0.01%	3677
2024 Q3	$12.4K	Sell	127 -193	-60%	-$24.9K	﹤0.01%	3280
2024 Q2	$52.4K	Buy	320 +195	+156%	+$27.8K	﹤0.01%	2652
2024 Q1	$19.1K	Buy	125 +80	+178%	+$13.3K	﹤0.01%	3118
2023 Q4	$14.2K	Sell	45 -21	-32%	-$7.6K	﹤0.01%	3191
2023 Q3	$29.2K	Buy	66 +6	+10%	+$2.71K	﹤0.01%	2699
2023 Q2	$25.9K	Sell	60 -37	-38%	-$20.8K	﹤0.01%	2848
2023 Q1	$57.6K	Buy	97 +47	+94%	+$26.3K	﹤0.01%	2441
2022 Q4	$20.2K	Buy	50 +43	+614%	+$20.2K	﹤0.01%	2985
2022 Q3	$4K	Buy	+7	New	+$4.19K	﹤0.01%	3643

Other funds holding AGL

CDR

Clayton Dubilier & Rice New York $895M AUM 792.56% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

NPCM

North Peak Capital Management New York $900M AUM 193.67% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

DCP

Durable Capital Partners Bethesda, Maryland $10.3B AUM 29.04% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

US Bancorp's AGL Position: Q2 2026 in Review

US Bancorp opened a new position in Agilon Health (AGL) in Q2 2026: 36 shares worth $3.86K. The stake represents ﹤0.01% of the portfolio and ranks #3725 among its holdings. This is a return to the name: US Bancorp previously reported a position in AGL as recently as Q2 2025.

US Bancorp first reported a position in AGL in Q3 2022 and has held it in 13 quarters since. The position peaked at $88.4K in Q2 2025. 179 funds tracked by Wall St. Rank hold AGL as of Q2 2026.

US Bancorp held 36 shares of Agilon Health worth $3.86K as of Q2 2026.
Agilon Health was a new US Bancorp position in Q2 2026.
Agilon Health made up ﹤0.01% of US Bancorp's portfolio in Q2 2026, its #3725 holding.
US Bancorp first reported a position in Agilon Health in Q3 2022 and has held it in 13 quarters since.
US Bancorp's Agilon Health position peaked at $88.4K in Q2 2025.
179 funds tracked by Wall St. Rank held Agilon Health as of Q2 2026.

Based on US Bancorp's 13F filing for Q2 2026, filed 12 Aug 2026.